Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Discover which stablecoins pay interest safely and how to assess counterparty risk. This guide helps you compare options and reduce exposure while earning yields.
23,805 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Seoul lawmakers push to scrap the 22% crypto gains tax slated for 2025, arguing the policy is unfair to everyday inve...
Federal bank regulators announced a three-part plan to revise capital rules for mortgage assets, aiming to lift origi...
AppLovin posted stronger-than-expected Q4 results with robust margins and a strategic pivot to e-commerce ads, while ...
A Seattle federal judge denied Northwest MLS's bid to dismiss Compass’s antitrust lawsuit, keeping the Compass case o...
Through March 21, 2026, VT is down less than 1% year-to-date while SPY slides about 3%, signaling a shift toward glob...
Investors weigh growth plans and political headlines as DJT faces a volatile path to profitability, with forecasts sp...
An executive sale of shares often sparks questions. This article unpacks what cheesecake factory sells $328000 means ...
Geopolitical tensions between the U.S. and Iran are dominating crypto moves, with Bitcoin and XRP trading in tight ra...